Fig. 7

Graphical summary of MSC-EV-based DKD therapy. EVs derived from hP-MSCs alleviated DKD-induced renal injury and glomerular fibrosis. miR-99b-5p transferred by MSC-EVs targets and inhibits mTOR, promoting autophagy, which relieves the proliferation and ECM accumulation of glomerular mesangial cells